Biomarkers and Choroidal Neovascularization

Active, not recruitingOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

July 6, 2020

Primary Completion Date

January 6, 2027

Study Completion Date

July 6, 2027

Conditions
Choroidal NeovascularizationMineralocorticoid Excess
Interventions
OTHER

Blood and aqueous humor biomarker of treatment response

Blood analyses and aqueous humor analysis

Trial Locations (2)

75014

Ophtalmopole Hôpital Cochin, Paris

92150

Hôpital Foch, Suresnes

All Listed Sponsors
lead

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV